Concepedia

E. del Barco

ED

40

Publications

2.2K

Citations

22

H-Index

2003

Active since

Affiliations

Institut Català d'Oncologia(Current)

Complejo Hospitalario de Salamanca

Hospital Universitario Puerta de Hierro Majadahonda

Hospital General Universitario de Alicante Doctor Balmis

Hospital Universitario Fundación Jiménez Díaz

E. del Barco is an author at Institut Català d'Oncologia specializing in medicine, oncology, and radiation oncology.

ORCID

Top concepts

Publications per year

2003–2023

40

Publications

40

Neoadjuvant chemotherapy and nivolumab in resectable non-small-cell lung cancer (NADIM): an open-label, multicentre, single-arm, phase 2 trial

Mariano Provencio, Ernest Nadal, Amelia Insa et al. · The Lancet Oncology · 2020 · 788 citations

, , +4

Overall Survival and Biomarker Analysis of Neoadjuvant Nivolumab Plus Chemotherapy in Operable Stage IIIA Non–Small-Cell Lung Cancer (NADIM phase II trial)

Mariano Provencio, Roberto Serna‐Blasco, Ernest Nadal et al. · Journal of Clinical Oncology · 2022 · 322 citations · Full text

Lung cancer in Spain: information from the Thoracic Tumors Registry (TTR study)

Mariano Provencio, Enric Carcereny, Delvys Rodríguez‐Abreu et al. · Translational Lung Cancer Research · 2019 · 86 citations · Full text

Neoadjuvant chemo/immunotherapy for the treatment of stages IIIA resectable non-small cell lung cancer (NSCLC): A phase II multicenter exploratory study—NADIM study-SLCG.

Mariano Provencio-Pulla, Ernest Nadal-Alforja, Manuel Cobo et al. · Journal of Clinical Oncology · 2018 · 68 citations

, , +12

Neoadjuvant chemo-immunotherapy for the treatment of stage IIIA resectable non-small-cell lung cancer (NSCLC): A phase II multicenter exploratory study—Final data of patients who underwent surgical assessment.

Mariano Provencio, Ernest Nadal, Amelia Insa et al. · Journal of Clinical Oncology · 2019 · 61 citations

, , +14

Rows per page

1–5 of 40